GE HealthCare Technologies Inc. (GEHC) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 93.57
(+14.11%)
Based on the GE HealthCare Technologies Inc. stock forecast from 6 analysts, the average analyst target price for GE HealthCare Technologies Inc. is USD 93.57 over the next 12 months. GE HealthCare Technologies Inc.’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of GE HealthCare Technologies Inc. is Slightly Bullish , which is based on 10 positive signals and 6 negative signals. At the last closing, GE HealthCare Technologies Inc.’s stock price was USD 82.00. GE HealthCare Technologies Inc.’s stock price has changed by -1.11% over the past week, -8.69% over the past month and +11.41% over the last year.
No recent analyst target price found for GE HealthCare Technologies Inc.
No recent average analyst rating found for GE HealthCare Technologies Inc.
Company Overview GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois. Read Less
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates t...Read More
Frequently Asked Questions About GE HealthCare Technologies Inc. (GEHC) Stock
Based on ratings from 6 analysts GE HealthCare Technologies Inc.'s stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 4 buy, 1 sell and 2 hold ratings.
GEHC stock's dividend yield is 0.14%.
Our analysis grades GEHC stock's dividend yield at F. This means that GEHC stock's dividend yield is above 10% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this GEHC may be a poor dividend stock for its sector.
Based on targets from 6 analysts, the average taret price for GEHC is USD 93.57 over the next 12 months. The maximum analyst target price is USD 102 while the minimum anlayst target price is USD 74.
GEHC stock's Price/Earning ratio is 23.89.
Our analysis grades GEHC stock's Price / Earning ratio at D-. This means that GEHC stock's Price/Earning ratio is above 39% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this GEHC may be fairly valued for its sector
The last closing price of GEHC's stock was USD 82.00.
The most recent market capitalization for GEHC is USD 39.84B.
Based on targets from 6 analysts, the average taret price for GEHC is projected at USD 93.57 over the next 12 months.
This means that GEHC's stock price may go up by +14.11% over the next 12 months.
We can't find any ETFs which contains GE HealthCare Technologies Inc.'s stock.
As per our most recent records GE HealthCare Technologies Inc. has 51,000 Employees.
GE HealthCare Technologies Inc.'s registered address is 500 West Monroe Street, Chicago, IL, United States, 60661.
You can get more information about it from GE HealthCare Technologies Inc.'s website at https://www.gehealthcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About GE HealthCare Technologies Inc. (GEHC) Stock
Based on ratings from 6 analysts GE HealthCare Technologies Inc.'s stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 4 buy, 1 sell and 2 hold ratings.
GEHC stock's dividend yield is 0.14%.
Our analysis grades GEHC stock's dividend yield at F. This means that GEHC stock's dividend yield is above 10% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this GEHC may be a poor dividend stock for its sector.
Based on targets from 6 analysts, the average taret price for GEHC is USD 93.57 over the next 12 months. The maximum analyst target price is USD 102 while the minimum anlayst target price is USD 74.
GEHC stock's Price/Earning ratio is 23.89.
Our analysis grades GEHC stock's Price / Earning ratio at D-. This means that GEHC stock's Price/Earning ratio is above 39% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this GEHC may be fairly valued for its sector
The last closing price of GEHC's stock was USD 82.00.
The most recent market capitalization for GEHC is USD 39.84B.
Based on targets from 6 analysts, the average taret price for GEHC is projected at USD 93.57 over the next 12 months.
This means that GEHC's stock price may go up by +14.11% over the next 12 months.
We can't find any ETFs which contains GE HealthCare Technologies Inc.'s stock.
As per our most recent records GE HealthCare Technologies Inc. has 51,000 Employees.
GE HealthCare Technologies Inc.'s registered address is 500 West Monroe Street, Chicago, IL, United States, 60661.
You can get more information about it from GE HealthCare Technologies Inc.'s website at https://www.gehealthcare.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GEHC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
